scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Hopewell PC | |
P2860 | cites work | The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial | Q29620785 |
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial | Q29620805 | ||
Natural history of human immunodeficiency virus infections in hemophiliacs: effects of T-cell subsets, platelet counts, and age. | Q33452645 | ||
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort | Q36895424 | ||
Pneumococcal polysaccharide vaccine | Q38219799 | ||
Bacterial pneumonia in patients with human immunodeficiency virus infection | Q38229000 | ||
Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: pathophysiology, therapy, and prevention | Q38663570 | ||
Tuberculosis and human immunodeficiency virus infection | Q38663578 | ||
Controlled chemoprophylaxis trials in tuberculosis. A general review | Q39002300 | ||
Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis | Q41342669 | ||
B-cell immunodeficiency in acquired immune deficiency syndrome | Q41431679 | ||
Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without AIDS. | Q44651113 | ||
Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City | Q45055408 | ||
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection | Q45839569 | ||
CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection | Q45845673 | ||
Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival | Q46306051 | ||
Aerosolized pentamidine as second line therapy in patients with AIDS and Pneumocystis carinii pneumonia. | Q54111182 | ||
Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men | Q58737476 | ||
Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS | Q68090731 | ||
Fansidar prophylaxis of Pneumocystis pneumonia in the acquired immunodeficiency syndrome | Q68804903 | ||
The combined toxicity of azidothymidine and antimycobacterial agents. A retrospective study | Q69595405 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1038-1044 | |
P577 | publication date | 1989-12-01 | |
P1433 | published in | Thorax | Q7796158 |
P1476 | title | Prevention of lung infections associated with human immunodeficiency virus infection | |
P478 | volume | 44 |
Q68271469 | A comparison of several agents with two delivery systems for the prevention of airway narrowing induced by nebulised pentamidine isethionate |
Q38546468 | Animal models of polymicrobial pneumonia |
Q36726943 | Medical management of AIDS patients. Bacterial and fungal infections. |
Q33935513 | Pneumococcal vaccine and HIV infection: report of a vaccine failure and reappraisal of its value in clinical practice |
Q36380969 | Pneumocystis carinii pneumonia after 40 years |
Q36235474 | Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications |
Q35246794 | The impact of the HIV epidemic on tuberculosis control programmes in developing countries |
Q36688887 | Tuberculosis and HIV co-infection: a practical therapeutic approach |
Search more.